跳至主要内容
临床试验/CTRI/2020/05/025064
CTRI/2020/05/025064招募中未知

Role of Albumin versus Plasmalyte A salt solution in improving Major Adverse Kidney Events within 30 days (MAKE30) in critically ill cirrhotic patients with sepsis- A Pilot Study.

Post Graduate Medical Education and Research Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Adults ( >18 years) admitted to ICU with cirrhosis and sepsis
  • 2)Hypotension (Mean Arterial Pressure (MAP) <65mmHg)
  • 3)Lactate levels >2 mmol/L (to pick even mild hypoperfusion)
  • 4)Clinical need for of a Central Venous Catheter (CVC) and arterial line

排除标准

  • 1)Severe pre-existing cardiopulmonary disease
  • 2)Active bleeding
  • 3)Cerebrovascular events
  • 4)Prior renal disease/need of renal replacement therapy
  • 5)Admission to ICU following liver transplantation, burns, cardiac surgery
  • 6)Brain death or likely brain death within 24 hours
  • 7)Previous adverse reaction to human albumin solution

研究者

发起方
Post Graduate Medical Education and Research Chandigarh

相似试验

Impact of fluids on kidney outcomes in critically... | 临床试验